• Chairman, Asian Fund for Cancer Research
  • Board Member, Board of Directors of the National Foundation for Cancer Research
  • Chief Executive Officer, Cure Brain Cancer Foundation
  • Strategic Advisor, AIM-HI Accelerator Fund

Mr. Kawaguchi is currently the Chief Executive Officer of Cure Brain Cancer Foundation, a non-profit organization in Australia dedicated to defeating brain cancer. To progress innovative therapeutics into the clinic rapidly, Mr. Kawaguchi Launched the world’s first brain cancer-dedicated Clinical Accelerator program to support early-stage biotechnology companies, researchers, and industry partners. Cure Brain Cancer Foundation led the critical funding to bring the revolutionary trial GBM AGILE to Australia, under the unwavering tenacity of Mr. Kawaguchi.

Mr. Kawaguchi currently serves as the Chairman of the Asian Fund for Cancer Research, is a Member of the Board of Directors of the National Foundation for Cancer Research and is the strategic advisor for the AIM-HI Accelerator Fund.

Recently Mr. Kawaguchi has been awarded the 2022 CEO Magazine Global Not-for-Profit Executive of the Year and the 2022 Third Sector CEO of the Year within the first full year leading the Foundation, being the only CEO to have received both awards within the same year. 

Mr. Kawaguchi has also recently been featured on the cover of CEO Magazine’s December edition and has fulfilled a lifelong dream when he was asked to ring the opening bell at Nasdaq’s MarketSite in Times Square, where he highlighted the importance of global collaboration and the establishment of a U.S. affiliate that will widely increase the impact of the organisation.